Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Yelena Janjigian"'
Autor:
Stephanie King, David Faleck, Yelena Janjigian, Steven B Maron, Darren Cowzer, Patrick T Magahis, Mark Schattner, Monika Laszkowska
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 10 (2023)
Background Gut microbiota composition can influence cancer immunotherapy response. Recent evidence suggests Helicobacter pylori infection may reduce immune checkpoint inhibitor (ICI) efficacy in lung cancer and melanoma, but thorough characterization
Externí odkaz:
https://doaj.org/article/04baa71c765345c2895d824f70e4808e
Autor:
Paul Chapman, Mario E Lacouture, Lukas kraehenbuehl, Alyce Mei-Shiuan Kuo, Stephanie Gu, Joseph Stoll, Andrea P Moy, Stephen W Dusza, Allison Gordon, Elena C Haliasos, Yelena Janjigian, Elizabeth A Quigley, Alina Markova
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 6 (2023)
Immune checkpoint inhibitors (ICI) target the PD-1/PD-L1 and CTLA-4 pathways and allows the immune system to deliver antitumor effects. However, it is also associated with well-documented immune-related cutaneous adverse events (ircAEs), affecting up
Externí odkaz:
https://doaj.org/article/6e5a3ab13eac4fd5b7c33c92be3e1a08
Autor:
Suhasini Joshi, Erica DaGama Gomes, Tai Wang, Adriana Corben, Tony Taldone, Srinivasa Gandu, Chao Xu, Sahil Sharma, Salma Buddaseth, Pengrong Yan, Lon Yin L. Chan, Askan Gokce, Vinagolu K. Rajasekhar, Lisa Shrestha, Palak Panchal, Justina Almodovar, Chander S. Digwal, Anna Rodina, Swathi Merugu, NagaVaraKishore Pillarsetty, Vlad Miclea, Radu I. Peter, Wanyan Wang, Stephen D. Ginsberg, Laura Tang, Marissa Mattar, Elisa de Stanchina, Kenneth H. Yu, Maeve Lowery, Olivera Grbovic-Huezo, Eileen M. O’Reilly, Yelena Janjigian, John H. Healey, William R. Jarnagin, Peter J. Allen, Chris Sander, Hediye Erdjument-Bromage, Thomas A. Neubert, Steven D. Leach, Gabriela Chiosis
Publikováno v:
Communications Biology, Vol 4, Iss 1, Pp 1-20 (2021)
Joshi, Gomes et al. employ a chemical modulation approach of the cellular interactome to a hyperconnectivity state and show association with the increased response of pancreatic cancer cell lines to specific drugs, including those that target the MAP
Externí odkaz:
https://doaj.org/article/c73d69998238486ba39d6f85c901b64d
Autor:
Zachary Boyd, Ian Chau, Filippo de Braud, Thomas R. Jeffry Evans, Johanna Bendell, Padmanee Sharma, Patrick A. Ott, Yelena Janjigian, Peter M. Szabo, Christopher Harbison, Teresa Sanchez, Han Chang, Dimple Pandya, Nathan O. Siemers, Ming Lei
Supplementary Material
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9522537b32eed18f18dcf3a1c1097324
https://doi.org/10.1158/1078-0432.22481259.v1
https://doi.org/10.1158/1078-0432.22481259.v1
Autor:
Zachary Boyd, Ian Chau, Filippo de Braud, Thomas R. Jeffry Evans, Johanna Bendell, Padmanee Sharma, Patrick A. Ott, Yelena Janjigian, Peter M. Szabo, Christopher Harbison, Teresa Sanchez, Han Chang, Dimple Pandya, Nathan O. Siemers, Ming Lei
Purpose:In advanced gastric cancer/gastroesophageal junction cancer (GC/GEJC), there is a need to identify biomarkers of response to therapies, such as immune checkpoint inhibitors.Patients and Methods:In post hoc exploratory analyses from CheckMate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e87927031a61e65f5923467f0c87959b
https://doi.org/10.1158/1078-0432.c.6530646.v1
https://doi.org/10.1158/1078-0432.c.6530646.v1
Autor:
Zachary Boyd, Ian Chau, Filippo de Braud, Thomas R. Jeffry Evans, Johanna Bendell, Padmanee Sharma, Patrick A. Ott, Yelena Janjigian, Peter M. Szabo, Christopher Harbison, Teresa Sanchez, Han Chang, Dimple Pandya, Nathan O. Siemers, Ming Lei
Gene expression levels by cohort
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80f09d1681d4fbca853b5013a2d27119
https://doi.org/10.1158/1078-0432.22481250.v1
https://doi.org/10.1158/1078-0432.22481250.v1
Autor:
Zachary Boyd, Ian Chau, Filippo de Braud, Thomas R. Jeffry Evans, Johanna Bendell, Padmanee Sharma, Patrick A. Ott, Yelena Janjigian, Peter M. Szabo, Christopher Harbison, Teresa Sanchez, Han Chang, Dimple Pandya, Nathan O. Siemers, Ming Lei
Corresponding % TC and CPS with response and OS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::384273ce28f5a506719d5a6b3973d90c
https://doi.org/10.1158/1078-0432.22481253
https://doi.org/10.1158/1078-0432.22481253
Autor:
Zachary Boyd, Ian Chau, Filippo de Braud, Thomas R. Jeffry Evans, Johanna Bendell, Padmanee Sharma, Patrick A. Ott, Yelena Janjigian, Peter M. Szabo, Christopher Harbison, Teresa Sanchez, Han Chang, Dimple Pandya, Nathan O. Siemers, Ming Lei
Additional details on CPS scoring done by Agilent-certified pathologists
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f02e47cbe52ecb440674aed62678056
https://doi.org/10.1158/1078-0432.22481256.v1
https://doi.org/10.1158/1078-0432.22481256.v1
Autor:
Manish A. Shah, Erin B. Kennedy, Ashley E. Alarcon-Rozas, Thierry Alcindor, Angela N. Bartley, Aubrey Belk Malowany, Nishin A. Bhadkamkar, Dana C. Deighton, Yelena Janjigian, Asha Karippot, Uqba Khan, Daniel A. King, Kelsey Klute, Jill Lacy, James J. Lee, Rutika Mehta, Sarbajit Mukherjee, Arun Nagarajan, Haeseong Park, Anwaar Saeed, Thomas J. Semrad, Kohei Shitara, Elizabeth Smyth, Nataliya V. Uboha, Melani Vincelli, Zev Wainberg, Lakshmi Rajdev
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
PURPOSE To develop recommendations involving targeted therapies for patients with advanced gastroesophageal cancer. METHODS The American Society of Clinical Oncology convened an Expert Panel to conduct a systematic review of relevant studies and deve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c6ff95cf0ea6cda10c66173c65a6df5
https://pubmed.ncbi.nlm.nih.gov/36603169
https://pubmed.ncbi.nlm.nih.gov/36603169
Autor:
Funda Meric-Bernstam, Yelena Janjigian, Joshua Lang, Kristen K. Ciombor, Isabelle Ray-Coquard, Amit Oza, Kan Yonemori, Ruihua Xu, Jimmy L. Zhao, Srikanth Gajavelli, Justyna Filant, Tina Hovey, Ana Oaknin
Publikováno v:
Cancer Research. 83:CT058-CT058
Background: Pts with metastatic epithelial tumors who progress after initial therapy have a poor prognosis; new therapeutic agents could potentially improve outcomes. Trophoblast cell surface protein 2 (TROP2) is a transmembrane glycoprotein that is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a2bf9849d4452c38d5f8b332ab180f5
https://doi.org/10.1158/1538-7445.am2023-ct058
https://doi.org/10.1158/1538-7445.am2023-ct058